Use of Electronic Personal Health Records to Improve Medication Adherence
The Use of Electronic Personal Health Records to Improve Medication Adherence Among Non-Valvular Atrial Fibrillation Patients: A Pilot Study
研究概览
详细说明
Three brief newsletters will be sent by the research staff to the study patients in the form of secure messages through their MyChart account. The newsletters will describe dabigatran tolerability, adverse effects, patient monitoring, warnings/precautions, and administration. Newsletters will be developed through a review of the FDA-approved prescribing information, general tertiary references, and a search of PubMed and drafted with guidance from a Drug Information Specialist at Manchester University College of Pharmacy as well as reviewed by the research staff.
Descriptive analysis will be used to analyze the survey to assess patient attitudes and beliefs about dabigatran and personal health records, as well as to assess the level of patient engagement. Difference-in-difference regression analysis will be used to evaluate the impact of the personal health record on dabigatran adherence by comparing the differences between times (pre-post) and interventions. Patient medication adherence will be correlated from the Pharmacy refill data to determine if the Intervention Group is more compliant than the Control Group. Multivariate analysis will be used to explore factors influencing personal health record use and dabigatran adherence.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Indiana
-
Fort Wayne、Indiana、美国、46845
- Parkview Research Center; Parkview Health
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Age ≥ 18 years
- Patient of Parkview Physicians Group-Cardiology
- Currently on dabigatran for non-valvular atrial fibrillation
- Out-patient status
- Ability to read and understand English
- Access to the Internet
- Ability to utilize the computer and Internet
- Willingness to enroll in a MyChart account
Exclusion Criteria:
- Physical or cognitive disability hindering provision of the informed consent process or performance of study tasks
- Unable to physically or cognitively carry out the tasks necessary for activating and/or utilizing a personal health record
- Designated as part of a vulnerable subject population that the investigator or designee identifies to have compromised autonomy related to potential study participation
- Currently part of another study involving another type of personal health record (other than MyChart)
学习计划
研究是如何设计的?
设计细节
- 主要用途:其他
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
实验性的:Medication Education
Patients will receive training on the use of the personal health record and health education via the personal health record.
|
Medication education delivered via the personal health record (MyChart) pertinent to the anticoagulation medication dabigatran.
Education newsletters will be sent at 4, 6, and 10 weeks post-enrollment.
|
无干预:No Medication Education
Patients will receive the current standard of care for the personal health record.
Patients will not receive training on the use of the personal health record or health education via the personal health record.
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
---|---|
Medication Adherence evaluated through medication possession ratios
大体时间:3 months during study
|
3 months during study
|
次要结果测量
结果测量 |
大体时间 |
---|---|
Patient Engagement evaluated through Patient Activation Measure (PAM)
大体时间:3 months during study
|
3 months during study
|
Medication Knowledge evaluated through 5-question survey
大体时间:3 months during study
|
3 months during study
|
合作者和调查者
调查人员
- 首席研究员:Michael Mirro, MD、Parkview Health
- 首席研究员:Ozlem Ersin, PhD、Manchester University College of Medicine
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
Medication Education的临床试验
-
University of SheffieldUniversity of Liverpool; University of Manchester; University of Melbourne主动,不招人
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and Infectious Diseases...邀请报名